by Dr. Claire Bracquemart
For several years, cytogenetics has often been said to face a bleak future – and yet, the demand has never been higher than it is today.
Together, let’s take a closer look at this discipline within the management of malignant hemopathies.
On December 12, we gathered to highlight the role of onco-hematological cytogenetics through simple and concrete examples. We also explored practical aspects such as the challenges of the pre-analytical phase, and learned how to interpret results step by step.
